Role of miR-7-5p in Diffuse Large B-Cell Lymphoma
Author Information
Author(s): Zhang Cuifen, Wang Ke, Tao Jiahao, Zheng Chuangjie, Zhai Linzhu
Primary Institution: Guangzhou University of Chinese Medicine
Hypothesis
This study investigates whether miR-7-5p regulates AMBRA1 and its effects on autophagy and apoptosis in diffuse large B-cell lymphoma (DLBCL).
Conclusion
The study concludes that miR-7-5p suppresses autophagy and apoptosis in DLBCL by targeting AMBRA1.
Supporting Evidence
- MiR-7-5p was found to be upregulated in DLBCL cells.
- Luciferase reporter assays confirmed AMBRA1 as a target of miR-7-5p.
- Overexpression of miR-7-5p decreased apoptosis in DLBCL cells.
- Silencing AMBRA1 led to increased apoptosis and decreased autophagy.
- Hydroxychloroquine, an autophagy inhibitor, increased apoptosis in DLBCL cells.
- In vivo experiments showed that miR-7-5p overexpression increased tumor volume and weight.
- MiR-7-5p and c-MYC were found to have a positive feedback loop.
Takeaway
Researchers found that a tiny molecule called miR-7-5p can help cancer cells survive by stopping them from dying, which could be important for treating a type of blood cancer.
Methodology
The study used quantitative real-time PCR, transfection of miRNA mimics and inhibitors, dual-luciferase reporter assays, immunofluorescence, flow cytometry, and western blotting to assess the effects of miR-7-5p on autophagy and apoptosis.
Limitations
The study did not assess miR-7-5p levels in clinical DLBCL samples for further validation.
Participant Demographics
Sixteen female SCID mice were used in the in vivo experiments.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website